Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1CNS 1Breast 1

Conditions

Brain Neoplasms 19Breast Neoplasms 14Glioblastoma 4Squamous Cell Carcinoma of Head and Neck 3Salivary Gland Neoplasms 3Neoplasm Metastasis 3Esthesioneuroblastoma, Olfactory 3Stomach Neoplasms 2Neoplasms 2Meningeal Neoplasms 2Meningeal Carcinomatosis 2Head and Neck Neoplasms 2Glioma 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Bile Duct Neoplasms 2Astrocytoma 2Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Pancreatic Neoplasms 1Oligodendroglioma 1Neoplasms, Unknown Primary 1Liver Neoplasms 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Appendiceal Neoplasms 1

Interventions

bosutinib 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Breast Cancer (Parts 1 and 2) × Capecitabine × CNS × Clear all
NCT00959946 2013-02-22

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

Pfizer

Phase 1/2 Terminated
32 enrolled 15 charts
BreastCNSGastrointestinal

Advanced Breast Cancer (Parts 1 and 2)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡